Clinical Trial Update: Stress Urinary Incontinence Study to Assess Safety and Efficacy of Muvon's Muscle Precursor Cell Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of Muvon's muscle precursor cell therapy for female stress urinary incontinence has completed. The update notes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Urinary Incontinence

Drugs mentioned

• Muvon's Muscle Precursor Cell Therapy

Snippet

Sponsor: University of Zurich | Conditions: Female Stress Urinary Incontinence | Phase 2 | Status: COMPLETED